Timeline: International Phase 3 Clinical Trial of Verdiperstat in Multiple System Atrophy
“Top line results from the study are expected to be available in 3rd Quarter of 2021 and will help to characterize the potential benefits and risks of Verdiperstat in MSA. After the study results are available, Biohaven will provide further updates on the development of Verdiperstat for the treatment of MSA.”
For information on the Mechanism of Action (MOA), please click below to access a video explaining Verdiperstat:
CLICK HERE TO DOWNLOAD UPDATE FROM BIOHAVEN MAY 2021
CLICK BELOW TO VIEW VIDEO ON VERDIPERSTAT FROM BIOHAVEN:
When will verdiperstat be available for purchase?
We don’t know the answer to your question. It all depends on whether Verdiperstat is approved by the US FDA, which is the authority for drugs in the US. Currently, the only way to obtain the drug is through a early access program by a doctor: https://www.biohavenpharma.com/science-pipeline/resources/early-access-programs
When Is Verdiperstat Drugs available for MSA treatment?
We do not know. Biohaven, the company producing it will make an announcement about the drug trial results at the end of September or October. After that, if the result is good, the company will apply to the US government for approval. Stay up to date on research by registering on our research hub: https://defeatmsa.org/research-registry/